1393 related articles for article (PubMed ID: 25408216)
1. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
[TBL] [Abstract][Full Text] [Related]
2. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS
Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521
[TBL] [Abstract][Full Text] [Related]
3. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice.
Devi L; Ohno M
Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928
[TBL] [Abstract][Full Text] [Related]
4. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
Paouri E; Tzara O; Zenelak S; Georgopoulos S
J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
[TBL] [Abstract][Full Text] [Related]
5. Gene Dosage Dependent Aggravation of the Neurological Phenotype in the 5XFAD Mouse Model of Alzheimer's Disease.
Richard BC; Kurdakova A; Baches S; Bayer TA; Weggen S; Wirths O
J Alzheimers Dis; 2015; 45(4):1223-36. PubMed ID: 25697701
[TBL] [Abstract][Full Text] [Related]
6. Effects of BACE1 haploinsufficiency on APP processing and Aβ concentrations in male and female 5XFAD Alzheimer mice at different disease stages.
Devi L; Ohno M
Neuroscience; 2015 Oct; 307():128-37. PubMed ID: 26314636
[TBL] [Abstract][Full Text] [Related]
7. Impaired performance of female APP/PS1 mice in the Morris water maze is coupled with increased Aβ accumulation and microglial activation.
Gallagher JJ; Minogue AM; Lynch MA
Neurodegener Dis; 2013; 11(1):33-41. PubMed ID: 22627185
[TBL] [Abstract][Full Text] [Related]
8. Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse.
Dinkins MB; Enasko J; Hernandez C; Wang G; Kong J; Helwa I; Liu Y; Terry AV; Bieberich E
J Neurosci; 2016 Aug; 36(33):8653-67. PubMed ID: 27535912
[TBL] [Abstract][Full Text] [Related]
9. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
10. Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain.
Wang S; Wang R; Chen L; Bennett DA; Dickson DW; Wang DS
J Neurochem; 2010 Oct; 115(1):47-57. PubMed ID: 20663017
[TBL] [Abstract][Full Text] [Related]
11. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice.
Devi L; Ohno M
Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558
[TBL] [Abstract][Full Text] [Related]
12. 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease.
Choi IS; Lee YJ; Choi DY; Lee YK; Lee YH; Kim KH; Kim YH; Jeon YH; Kim EH; Han SB; Jung JK; Yun YP; Oh KW; Hwang DY; Hong JT
J Alzheimers Dis; 2011; 27(1):127-41. PubMed ID: 21799245
[TBL] [Abstract][Full Text] [Related]
13. Beta-amyloid secretases and beta-amloid degrading enzyme expression in lens.
Li G; Percontino L; Sun Q; Qazi AS; Frederikse PH
Mol Vis; 2003 May; 9():179-83. PubMed ID: 12740567
[TBL] [Abstract][Full Text] [Related]
14. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y
Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846
[TBL] [Abstract][Full Text] [Related]
15. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
[TBL] [Abstract][Full Text] [Related]
16. Deletion of the Inflammasome Sensor Aim2 Mitigates Aβ Deposition and Microglial Activation but Increases Inflammatory Cytokine Expression in an Alzheimer Disease Mouse Model.
Wu PJ; Hung YF; Liu HY; Hsueh YP
Neuroimmunomodulation; 2017; 24(1):29-39. PubMed ID: 28618410
[TBL] [Abstract][Full Text] [Related]
17. Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease.
Yang H; Yang H; Xie Z; Wang P; Bi J
Neurol Res; 2015 Jan; 37(1):84-91. PubMed ID: 25005263
[TBL] [Abstract][Full Text] [Related]
18. Environmental enrichment lessens cognitive decline in APP23 mice without affecting brain sirtuin expression.
Polito L; Chierchia A; Tunesi M; Bouybayoune I; Kehoe PG; Albani D; Forloni G
J Alzheimers Dis; 2014; 42(3):851-64. PubMed ID: 24961946
[TBL] [Abstract][Full Text] [Related]
19. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice.
Kimura R; Devi L; Ohno M
J Neurochem; 2010 Apr; 113(1):248-61. PubMed ID: 20089133
[TBL] [Abstract][Full Text] [Related]
20. Major amyloid-β-degrading enzymes, endothelin-converting enzyme-2 and neprilysin, are expressed by distinct populations of GABAergic interneurons in hippocampus and neocortex.
Pacheco-Quinto J; Eckman CB; Eckman EA
Neurobiol Aging; 2016 Dec; 48():83-92. PubMed ID: 27644077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
